Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
5.99
+0.05 (0.84%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $506.90 million as of October 29, 2024. Its market cap has decreased by -32.01% in one year.
Market Cap
506.90M
Enterprise Value
3.43M
1-Year Change
-32.01%
Ranking
Category
Stock Price
$5.99
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $506.90M, a decrease of -41.69%. That is a compound annual growth rate of -14.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 28, 2024 | 502.70M | -43.43% |
Dec 29, 2023 | 888.70M | -25.44% |
Dec 30, 2022 | 1.19B | -32.89% |
Dec 31, 2021 | 1.78B | 104.31% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Canopy Growth | 512.13M |
Larimar Therapeutics | 511.09M |
Allogene Therapeutics | 510.23M |
UroGen Pharma | 509.58M |
EyePoint Pharmaceuticals | 508.42M |
KalVista Pharmaceuticals | 504.76M |
Aquestive Therapeutics | 499.92M |
Revance Therapeutics | 492.67M |